RxDoctor Payments DataLook up a doctor →

Tony Philip, MD

Hematology & Oncology · New Hyde Park, NYNPI 1174772982

Payments from drug & device makers

$2,516,244in general payments, 2019–2025

Across 285 payments — averaging $8828.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Deciphera Pharmaceuticals Inc.$1.7M
  • Daiichi Sankyo Inc.$285K
  • Boehringer Ingelheim$201K
  • EMD Serono, Inc.$132K
  • Karyopharm Therapeutics Inc.$97K
  • Eli Lilly$61K
  • plus $48K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,516,244 in reported general payments places this provider in the 90th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Medicare billing

Part B allowed, 2024
$85,328
Medicare patients
199
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →